Mr. Adam Ho reports

ARCPOINT PROVIDES LEADERSHIP UPDATE

Peter Kendall has stepped down as interim chief executive officer of Arcpoint Inc., having completed his mandate and delivered his assessment and recommendations to the board of directors. Mr. Kendall was appointed interim chief executive officer on June 9, 2026, for an initial 90-day term to work with the board and management to assess the company's business model, its MyArcpointLabs technology platform, commercial relationships, assets and strategic direction, and to provide recommendations to the board on commercial and financial paths forward. The board is now considering those recommendations as it determines the company's next steps.

The board thanks Mr. Kendall for his contributions to the company and will seek to appoint a new chief executive officer as soon as practically possible.

As announced on June 9, 2026, the company agreed to grant four million restricted share units to Mr. Kendall. In connection with the conclusion of his engagement, the number of RSUs granted has been prorated to reflect the portion of the 90-day term served, and has accordingly been reduced from four million to two million RSUs. Each RSU entitles the holder to receive one Class A subordinate voting share of the company upon vesting, which is scheduled to occur on the date that is 12 months following June 9, 2026. RSU grants are under the company's omnibus security-based compensation plan and are subject to acceptance by the TSX Venture Exchange, available capacity under the plan, applicable participant limits and other requirements of TSX-V Policy 4.4, applicable securities laws, and, if required, disinterested shareholder approval. Mr. Kendall will also continue to provide advisory consulting services to the company, maintaining his eligibility under the plan pending vesting of the RSUs.

About Arcpoint Inc.

Arcpoint is a health care technology company that owns and develops MAPL, a multitenant software platform for clinical lab ordering, scheduling and results delivery used by laboratories, collection sites and other health care service providers in the United States. Arcpoint's Class A subordinate voting shares trade on the TSX Venture Exchange under the symbol ARC.

We seek Safe Harbor.